These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
178 related items for PubMed ID: 22739025
1. IL-6-induced DNMT1 activity mediates SOCS3 promoter hypermethylation in ulcerative colitis-related colorectal cancer. Li Y, Deuring J, Peppelenbosch MP, Kuipers EJ, de Haar C, van der Woude CJ. Carcinogenesis; 2012 Oct; 33(10):1889-96. PubMed ID: 22739025 [Abstract] [Full Text] [Related]
2. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis. Li Y, de Haar C, Chen M, Deuring J, Gerrits MM, Smits R, Xia B, Kuipers EJ, van der Woude CJ. Gut; 2010 Feb; 59(2):227-35. PubMed ID: 19926618 [Abstract] [Full Text] [Related]
3. High suppressor of cytokine signaling-3 expression impairs STAT3-dependent protective effects of interleukin-22 in ulcerative colitis in remission. Xu AT, Li Y, Zhao D, Shen J, Xu XT, Qiao YQ, Zhu MM, Wang TR, Cui Y, Ai LY, Ran ZH. Inflamm Bowel Dis; 2015 Feb; 21(2):241-50. PubMed ID: 25545374 [Abstract] [Full Text] [Related]
4. IL-23 selectively promotes the metastasis of colorectal carcinoma cells with impaired Socs3 expression via the STAT5 pathway. Zhang L, Li J, Li L, Zhang J, Wang X, Yang C, Li Y, Lan F, Lin P. Carcinogenesis; 2014 Jun; 35(6):1330-40. PubMed ID: 24464786 [Abstract] [Full Text] [Related]
5. Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis. Huang L, Hu B, Ni J, Wu J, Jiang W, Chen C, Yang L, Zeng Y, Wan R, Hu G, Wang X. J Exp Clin Cancer Res; 2016 Feb 04; 35():27. PubMed ID: 26847351 [Abstract] [Full Text] [Related]
6. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC. Scarpa M, Scarpa M, Castagliuolo I, Erroi F, Kotsafti A, Basato S, Brun P, D'Incà R, Rugge M, Angriman I, Castoro C. Oncotarget; 2016 Mar 01; 7(9):10322-31. PubMed ID: 26862732 [Abstract] [Full Text] [Related]
7. STAT1, STAT6 and adenosine 3',5'-cyclic monophosphate (cAMP) signaling drive SOCS3 expression in inactive ulcerative colitis. Li Y, Deuring J, Peppelenbosch MP, Kuipers EJ, de Haar C, van der Woude CJ. Mol Med; 2012 Dec 20; 18(1):1412-9. PubMed ID: 23154639 [Abstract] [Full Text] [Related]
8. Qing Hua Chang Yin inhibits the LPS-induced activation of the IL-6/STAT3 signaling pathway in human intestinal Caco-2 cells. Ke X, Hu G, Fang W, Chen J, Zhang X, Yang C, Peng J, Chen Y, Sferra TJ. Int J Mol Med; 2015 Apr 20; 35(4):1133-7. PubMed ID: 25633437 [Abstract] [Full Text] [Related]
9. Increased expression of DNA methyltransferase-1 in non-neoplastic epithelium helps predict colorectal neoplasia risk in ulcerative colitis. Fujii S, Katake Y, Tanaka H. Digestion; 2010 Apr 20; 82(3):179-86. PubMed ID: 20588031 [Abstract] [Full Text] [Related]
10. Dysregulation of IL6/IL6R-STAT3-SOCS3 signaling pathway in IBD-associated colorectal dysplastic lesions as compared to sporadic colorectal adenomas in non-IBD patients. Gui X, Iacucci M, Ghosh S. Pathol Res Pract; 2020 Nov 20; 216(11):153211. PubMed ID: 32979687 [Abstract] [Full Text] [Related]
11. Clinical significance of mucosal suppressors of cytokine signaling 3 expression in ulcerative colitis. Miyanaka Y, Ueno Y, Tanaka S, Yoshioka K, Hatakeyama T, Shimamoto M, Sumii M, Chayama K. World J Gastroenterol; 2007 Jun 07; 13(21):2939-44. PubMed ID: 17589943 [Abstract] [Full Text] [Related]
12. Up-regulation of mitochondrial chaperone TRAP1 in ulcerative colitis associated colorectal cancer. Chen R, Pan S, Lai K, Lai LA, Crispin DA, Bronner MP, Brentnall TA. World J Gastroenterol; 2014 Dec 07; 20(45):17037-48. PubMed ID: 25493016 [Abstract] [Full Text] [Related]
13. Pien Tze Huang suppresses IL-6-inducible STAT3 activation in human colon carcinoma cells through induction of SOCS3. Shen A, Chen Y, Hong F, Lin J, Wei L, Hong Z, Sferra TJ, Peng J. Oncol Rep; 2012 Dec 07; 28(6):2125-30. PubMed ID: 23027374 [Abstract] [Full Text] [Related]
14. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia. Hanaoka M, Ishikawa T, Ishiguro M, Tokura M, Yamauchi S, Kikuchi A, Uetake H, Yasuno M, Kawano T. J Gastroenterol; 2018 May 07; 53(5):631-641. PubMed ID: 28884228 [Abstract] [Full Text] [Related]
15. Elevated IL-13Ralpha2 in intestinal epithelial cells from ulcerative colitis or colorectal cancer initiates MAPK pathway. Mandal D, Levine AD. Inflamm Bowel Dis; 2010 May 07; 16(5):753-64. PubMed ID: 20014020 [Abstract] [Full Text] [Related]
16. Expression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis. Yu LZ, Wang HY, Yang SP, Yuan ZP, Xu FY, Sun C, Shi RH. World J Gastroenterol; 2013 May 07; 19(17):2638-49. PubMed ID: 23674871 [Abstract] [Full Text] [Related]
17. Upregulation of DNA methyltransferase-mediated gene silencing, anchorage-independent growth, and migration of colon cancer cells by interleukin-6. Foran E, Garrity-Park MM, Mureau C, Newell J, Smyrk TC, Limburg PJ, Egan LJ. Mol Cancer Res; 2010 Apr 07; 8(4):471-81. PubMed ID: 20354000 [Abstract] [Full Text] [Related]
18. Expression of IL-24, an activator of the JAK1/STAT3/SOCS3 cascade, is enhanced in inflammatory bowel disease. Andoh A, Shioya M, Nishida A, Bamba S, Tsujikawa T, Kim-Mitsuyama S, Fujiyama Y. J Immunol; 2009 Jul 01; 183(1):687-95. PubMed ID: 19535621 [Abstract] [Full Text] [Related]
19. Methylation-associated dysregulation of the suppressor of cytokine signaling-3 gene in multiple myeloma. Wilop S, van Gemmeren TB, Lentjes MH, van Engeland M, Herman JG, Brümmendorf TH, Jost E, Galm O. Epigenetics; 2011 Aug 01; 6(8):1047-52. PubMed ID: 21934357 [Abstract] [Full Text] [Related]
20. Increased suppressor of cytokine signaling-3 expression predicts mucosal relapse in ulcerative colitis. Li Y, Nuij VJ, Baars JE, Biermann K, Kuipers EJ, Peppelenbosch MP, de Haar C, Janneke van der Woude C. Inflamm Bowel Dis; 2013 Jan 01; 19(1):132-40. PubMed ID: 22535619 [Abstract] [Full Text] [Related] Page: [Next] [New Search]